Syndax Pharmaceuticals Inc

CHARLES SCHWAB INVESTMENT MANAGEMENT INC SNDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

727,424

Value ($000)

15,283

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	15,283	0.0%	727,424	12/31/2025
2025 Q3	11/10/2025	11,062	0.0%	719,034	9/30/2025
2025 Q2	8/12/2025	6,671	0.0%	712,310	6/30/2025
2025 Q1	9/15/2025	8,473	0.0%	689,693	3/31/2025
2024 Q4	2/6/2025	9,318	0.0%	704,823	12/31/2024
2024 Q3	11/12/2024	13,397	0.0%	695,947	9/30/2024
2024 Q2	8/12/2024	13,437	0.0%	654,489	6/30/2024
2024 Q1	5/9/2024	15,118	0.0%	635,207	3/31/2024
2023 Q4	2/6/2024	12,469	0.0%	577,022	12/31/2023
2023 Q3	11/8/2023	7,354	0.0%	506,467	9/30/2023
2023 Q2	8/10/2023	10,283	0.0%	491,311	6/30/2023
2023 Q1	5/12/2023	9,930	0.0%	470,166	3/31/2023
2022 Q4	2/13/2023	11,420	0.0%	448,741	12/31/2022
2022 Q3	11/14/2022	9,255	0.0%	385,121	9/30/2022
2022 Q2	8/15/2022	6,867	0.0%	356,905	6/30/2022
2022 Q1	5/13/2022	5,932	0.0%	341,304	3/31/2022
2021 Q4	2/11/2022	6,699	0.0%	305,996	12/31/2021
2021 Q3	11/16/2021	5,782	0.0%	302,527	9/30/2021
2021 Q2	8/16/2021	4,630	0.0%	269,631	6/30/2021
2021 Q1	5/17/2021	5,164	0.0%	230,933	3/31/2021
2020 Q4	2/16/2021	4,325	0.0%	194,468	12/31/2020
2020 Q3	11/13/2020	2,710	0.0%	183,568	9/30/2020
2020 Q2	8/20/2020	985	0.0%	66,419	6/30/2020
2020 Q1	5/15/2020	612	0.0%	55,758	3/31/2020
2019 Q4	2/7/2020	441	0.0%	50,164	12/31/2019